30,064 followers
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model https://t.co/IIDYpEtPCD [cc @LinvilleRaleigh, @LehtinenLab, @BarriersGroup] https://t.co/fawOqn2Rb3
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model https://t.co/IIDYpEtPCD [cc @LinvilleRaleigh, @LehtinenLab, @BarriersGroup] https://t.co/fawOqn2Rb3
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model https://t.co/EhI2L0YHFd